The Zacks Analyst Blog Highlights Mastercard, Verizon Communications, Stryker, Espey Mfg. & Electronics and Comstock Holding

For Immediate ReleaseChicago, IL – June 6, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mastercard Inc. MA, Verizon Communications Inc. VZ, Stryker Corp. SYK, Espey Mfg. & Electronics Corp. ESP and Comstock Holding Companies, Inc. CHCI.Here are highlights from Thursday’s Analyst Blog:Top Analyst Reports for Mastercard, Verizon and StrykerThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Mastercard Inc., Verizon Communications Inc. and Stryker Corp., as well as two micro-cap stocks Espey Mfg. & Electronics Corp. and Comstock Holding Companies, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Trump, Xi Speak; Jobless Claims, Productivity & Deficit Reports OutToday's Featured Research ReportsMastercard’s shares have outperformed the Zacks Financial Transaction Services industry over the past year (+31% vs. +27.8%). The company’s acquisitions are helping the company to grow addressable markets and drive new revenue streams.Mastercard expects mid-teens net revenue growth in 2Q25. The accelerated adoption of digital and contactless solutions is providing an opportunity for its business to expedite its shift to digital. Strong cash flows support its growth initiatives and enable shareholder value-boosting efforts through repurchases and dividends. MA repurchased shares worth $2.5 billion in 1Q25. Operating cash flows surged 42.3% YoY in the first quarter of 2025.However, MA's dividend yield is lower than the industry average. The Zacks analyst expects adjusted operating expenses to grow 14.8% year over year in 2025. High rebates and incentives may weigh on net revenues. As such, the stock warrants a cautious stance.(You can read the full research report on Mastercard here >>>)Shares of Verizon have outperformed the Zacks Wireless National industry over the past six months (+5.5% vs. +4.9%). The company is witnessing significant 5G adoption and fixed wireless broadband momentum. Its reliable, plug-and-play Internet connectivity, desk phone and security solutions with 24/7 tech support are driving the digital transformation of small business entities.Verizon’s mmWave footprint delivers game-changing experiences for the densest parts of the network and offers highly predictable signal waves, leading to greater efficiency and less interference for customers. The acquisition of Frontier Communications accelerates broadband expansion.However, the spectrum crunch has become a major issue in the U.S. telecom industry. Most of the carriers are finding it increasingly difficult to manage surging data traffic. High spending on promotional activities to attract customers is straining profit. Weakness in the wireline business is a concern.(You can read the full research report on Verizon here >>>)Stryker’s shares have outperformed the Zacks Medical - Products industry over the year-to-date period (+6.5% vs. +5.8%). The company is poised for growth, driven by rising demand for robotic-assisted procedures, hospital capital expenditures and international expansion. The Mako SmartRobotics platform fuels adoption, while acquisitions like Inari Medical and Vertos Medical enhance the portfolio.Stryker is actively integrating new technologies such as AI-driven imaging and smart surgical systems to improve patient outcomes and maintain its competitive edge. Pricing improvements and a strong hospital order book support growth in rest of 2025.However, foreign exchange volatility and acquisition-related margin pressures may impact earnings. Supply chain disruptions and rising costs could strain profitability. Intensifying competition in robotics and MedTech demands constant innovation. Macroeconomic risks, including potential downturns in healthcare spending and regulatory shifts, add uncertainty.(You can read the full research report on Stryker here >>>)Shares of Espey have outperformed the Zacks Electronics - Military industry over the year-to-date period (+33.5% vs. -3.5%). This microcap company with market capitalization of $112.89 million posted strong YTD FY25 results, with revenue up 26.7% to $34.4 million, driven by defense power supply programs and improved gross margins. Its record $138 million backlog — anchored by long-term contracts and key customer relationships — provides multi-year revenue visibility, with nearly half scheduled beyond FY26.Strategic wins include $49.3 million in multi-year contracts for the U.S. Navy’s Columbia-class submarines, supporting long-term positioning in electrification systems. A debt-free balance sheet, $28.3M in liquidity, and $10.8M in federal funding for capacity upgrades enhance strategic flexibility and throughput.Espey benefits from defense modernization tailwinds, especially in naval and airborne electrification. However, risks include persistent margin headwinds from early-stage programs, fixed cost pressures, and high customer concentration.(You can read the full research report on Espey here >>>)Comstock’s shares have outperformed the Zacks Building Products - Home Builders industry over the year-to-date period (+22% vs. -11.4%). This microcap company with market capitalization of $99.01 million benefits from stable, recurring revenue from asset management agreements extending through 2035, featuring cost-plus structures and performance incentives.Comstock’s debt-free, asset-light model enhances financial flexibility, while consistent revenue growth — 18.8% YoY in Q1 2025 — and expanding profitability demonstrate strong operational leverage. The company manages a high-quality, transit-oriented portfolio poised to scale to 10 million SF, with a defined development pipeline supporting future revenue growth.Strong tenant demand, long lease terms, and strategic alignment with urbanization further reinforce its defensible cash flows. However, risks include revenue concentration with a related party, low third-party diversification, and deferred incentive fee recognition. Regulatory headwinds and heavy geographic concentration in the D.C. metro area pose additional exposure.(You can read the full research report on Comstock here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Zacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mastercard Incorporated (MA): Free Stock Analysis Report Verizon Communications Inc. (VZ): Free Stock Analysis Report Stryker Corporation (SYK): Free Stock Analysis Report Espey Mfg. & Electronics Corp. (ESP): Free Stock Analysis Report Comstock Holding Companies, Inc. (CHCI): Get Free ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks